The 45% dementia figure is not a personal promise

A percentage can make a complicated health story look deceptively neat. The World Health Organization says up to 45 percent of dementia risk can be attributed to modifiable factors. Read quickly, that can sound like a promise that one person can remove nearly half of their risk by completing the right checklist. WHO’s new guideline says something more useful, and less marketable.

Published on 15 July, the second edition of WHO’s guideline on reducing cognitive decline and dementia risk replaces guidance issued in 2019. It is written mainly for health-care providers and policy-makers, and it treats risk as something that accumulates across the life course. Its scope runs from physical and social activity to tobacco, alcohol, diet, blood pressure, diabetes, hearing, vision, air pollution and several other health conditions.

That breadth is the first guardrail around the 45 percent headline. It is a population-level estimate about modifiable risk factors, not a forecast for an individual. It does not mean that dementia is always preventable, that everyone has the same starting risk, or that changing one habit produces a fixed reduction. Age remains the strongest known risk factor, and WHO’s fact sheet stresses both that dementia is not an inevitable part of ageing and that it can arise from several diseases and injuries that damage the brain.

There is also no single strength of evidence behind every item. In the guideline’s executive summary, physical activity for adults with normal cognition receives a strong recommendation supported by moderate-certainty evidence. Cognitive training for older adults with normal cognition or mild cognitive impairment is conditional, with low-certainty evidence. Cognitive stimulation and social-activity interventions are also conditional, with very low-certainty evidence. Those distinctions matter. A list of risk factors is not a menu of equally proven protective products.

The guideline is careful about what it does not recommend. For adults without an established deficiency, it recommends against using vitamin B or E supplements, omega-3 polyunsaturated fatty acids, or multivitamin and mineral supplements specifically to reduce cognitive decline or dementia risk. That recommendation is strong and based on moderate-certainty evidence. The point is not that diagnosed deficiencies should be ignored. It is that a supplement sold as “brain health” is not the same thing as evidence-based dementia prevention.

WHO instead places familiar public-health work in a wider frame. Tobacco cessation, physical activity and a healthy balanced diet overlap with the prevention and management of other noncommunicable diseases. Blood pressure, diabetes and cholesterol management appear because cardiometabolic health and brain health are connected. Hearing loss is included, with hearing aids among the approaches that may be offered as part of risk-reduction strategies. The new edition also adds reducing exposure to air pollution, moving part of the story outside the clinic and beyond personal choice.

That last point changes how the headline should be read. People do not individually control the quality of the air around their homes, the safety of walking routes, access to education, the availability of hearing care, or whether primary health services can identify and manage high blood pressure. WHO’s dementia fact sheet explicitly says risk reduction requires supportive systems and policies as well as individual action. A prevention message that ignores those conditions can turn public-health inequality into personal blame.

The guideline does not erase uncertainty. Its executive summary notes that evidence directly linking population-level policies to lower dementia incidence remains limited, except for air-pollution interventions. It also warns that some associations found late in life may reflect early disease processes rather than a simple cause. This is why timing, context and study design matter, and why the document identifies research gaps instead of presenting every recommendation as settled.

The scale of the issue makes that honesty important. WHO estimates that 57 million people were living with dementia in 2021, more than 60 percent of them in low- and middle-income countries, with nearly 10 million new cases each year. Dementia affects memory, thinking and the ability to carry out daily activities, but it is not one disease with one pathway. Alzheimer disease is the most common form, while vascular dementia, dementia with Lewy bodies and frontotemporal dementia are among the others.

For readers, the responsible takeaway is not a self-scoring exercise. The guideline does not assess anyone, calculate personal risk or replace clinical guidance for blood pressure, diabetes, hearing loss, depression or any other condition. It gives health systems a reason to connect work that is too often separated: noncommunicable-disease care, sensory health, social connection, healthy environments and brain health.

The 45 percent figure earns attention because it says dementia risk is not entirely beyond the reach of prevention policy. It becomes misleading when converted into a personal guarantee or a shopping list. WHO’s fuller message is slower and more demanding: reduce risks across a lifetime, distinguish strong evidence from tentative evidence, and build environments and services that make healthier lives possible for more than the people who can purchase them.